WHO strongly recommends Paxlovid after two trials show it reduced risk of hospitalization for Covid by 85%

 

US pharma giant Pfizer's combination of nirmatrelvir and ritonavir was the "superior choice" of treatment for unvaccinated, elderly or immunocompromised people with Covid, the WHO's experts said in the BMJ medical journal.

More.